7R4I

The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody

7R4I の概要

• エントリーDOI: 10.2210/pdb7r4i/pdb
• EMDBエントリー: 14313
• 分子名称: Spike glycoprotein, Camel-derived nanobody 2.15, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total)
• 機能のキーワード: coronavirus, covid-19, sars-cov-2, spike, nanobodies, neutralization, viral protein
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2; 詳細
• タンパク質・核酸の鎖数: 5
• 化学式量合計: 457702.55

構造登録者

Casasnovas, J.M.,Melero, R.,Arranz, R.,Fernandez, L.A. (登録日: 2022-02-08, 公開日: 2022-06-08)

• 主引用文献: Casasnovas, J.M.,Margolles, Y.,Noriega, M.A.,Guzman, M.,Arranz, R.,Melero, R.,Casanova, M.,Corbera, J.A.,Jimenez-de-Oya, N.,Gastaminza, P.,Garaigorta, U.,Saiz, J.C.,Martin-Acebes, M.A.,Fernandez, L.A.; Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron.; Front Immunol, 13:863831-863831, 2022; PubMed: 35547740; DOI: 10.3389/fimmu.2022.863831

実験手法

ELECTRON MICROSCOPY (3.2 Å)